Diabetes Prevention Through Genetics, Familial History and Behavior Change
- NCT ID
- NCT07815236
- Registry status
- Not yet recruiting
- Study type
- Not specified in the registry data
- Phase
- Phase 2 / Phase 3
- Sponsor
- Morehouse School of Medicine
Overview
ClinicalTrials.gov lists this study as Not yet recruiting.
Enrollment: 400 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- Yes
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* Age ≥18 years.
* Fasting HbA1c 5.7-6.4% confirmed by CLIA-waived point-of-care testing.
* BMI ≥25 kg/m².
* Able to provide informed consent.
* Has an adult household/family or framily (fictive kin) member willing to enroll as a paired participant.
* Willing to attend in-person sessions
Exclusion Criteria:
* Minors \<18 years
* Prior diagnosis of T1 or T2D.
* HbA1c ≥6.5% at screening (Aim 1/2 curriculum eligibility)
* Current glucose-lowering medication use
* Pregnancy
* Physical-activity contraindications
* Individuals unable to speak or understand English
Study locations
No study locations are listed in the registry data.
Study details
- Start date
- November 1, 2026
- Primary completion date
- January 31, 2031
- First posted
- September 11, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07815236
- Registry last updated
- September 11, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07815236 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Diabetes (Type II) studies | Clinical trial FAQ